The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (High-Grade) extrapulmonary neuroendocrine carcinomas

Pancreas

Volumn 39, Issue 6, 2010, Pages 799-800

  Strosberg, Jonathan R ^a   Coppola, Domenico ^a   Klimstra, David S ^b   Phan, Alexandria T ^c   Kulke, Matthew H ^d   Wiseman, Gregory A ^e   Kvols, Larry K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

Author keywords

high grade; neuroendocrine carcinomas; neuroendocrine tumors; poorly differentiated

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; CLINICAL PRACTICE; EXTRAPULMONARY NEUROENDOCRINE CARCINOMA; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; MEDICAL SOCIETY; METASTASIS; NEUROENDOCRINE TUMOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR CLASSIFICATION;

CARCINOMA, NEUROENDOCRINE; HUMANS;

EID: 77955198120     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181ebb56f     Document Type: Review

References (17)

1. Shia J, Tang LH, Weiser MR, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol. 2008;32(5):719Y731.
2. Kloppel G, Heitz PU, Capella C, et al. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg. 1996;20(2):132Y141.
3. Capella C, Heitz PU, Hofler H, et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425(6):547Y560.
4. Strosberg J, Nasir A, Coppola D, et al. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol. 2009;40(9):1262Y1268.
5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: SEER 17 Regs Nov 2006 sub (1973Y2004), (ed released April 2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistic Branch. 2006.
6. Walenkamp AM, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev. 2009;35(3):228Y236.
7. Yao JC, Hassan M, Phan A, et al. One hundred years after Bcarcinoid[: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J ClinOncol. 2008;26(18):3063Y3072.
8. Moertel CG, Kvols LK, O'Connell MJ, et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68(2):227Y232.
9. Mitry E, Baudin E, Ducreux M, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer. 1999;81(8):1351Y1355.
10. Lassen U, Kristjansen PE, Osterlind K, et al. Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up. Ann Oncol. 1996;7(4):365Y371.
11. Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol. 2006;24(13):2038Y2043.
12. O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol. 2006;24(34):5441Y5447.
13. Casas F, Ferrer F, Farrus B, et al. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. 1997;80(8):1366Y1372.
14. Brenner B, Shah MA, Gonen M, et al. Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer. 2004;90(9):1720Y1726.
15. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol. 2002;20(14):3054Y3060.
16. Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer. 2001;1:5.
17. Cicin I, Karagol H, Uzunoglu S, et al. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study. Cancer. 2007;110(5):1068Y1076.